{
    "nctId": "NCT05724407",
    "briefTitle": "Molecular Signature for Breast Cancer",
    "officialTitle": "Evaluation of the Use of a Diagnostic Assistance Tool of Prognostic and Predictive Marker Scoring System in Breast Cancer",
    "overallStatus": "NOT_YET_RECRUITING",
    "conditions": "Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 220,
    "primaryOutcomeMeasure": "Diagnostic performances",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Patients over 18 years of age\n* Understanding French\n* With symptoms of breast cancer that required a biopsy (microbiopsy or macrobiopsy or surgical biopsy) and pathological examination diagnosing breast cancer\n* First diagnosis of invasive breast cancercarcinoma\n* Affiliated to a social security system\n* Agreeing to participate in the study\n\nExclusion Criteria:\n\n* Refusal to participate in the study\n* Not affiliated to the social security system\n* Minor or under legal protection\n* Patient with a history of breast cancer\n* Patient previously treated for breast cancer\n* Patient who has relapsed from breast cancer treatment\n* Non ductal or non lobular invasive breast cancer carcinoma",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}